RxDoctor Payments Data

Odin Kuiper, MD

Obstetrics & Gynecology · Avon, CTNPI 1801987201

Payments from drug & device makers

$1,239in general payments, 2019–2025

Across 32 payments — averaging $38.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$397
  • Hologic Sales And Service, LLC$263
  • Medtronic$203
  • Acessa Health Inc.$197
  • Coloplast$39
  • Channel Medsystems, Inc.$36
  • plus $104 from 5 others
$50,658in research payments, 2019–2025

Across 43 payments — averaging $1178.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$26K
  • Covidien LP$25K

What the payments were for

  • Travel & lodging$59448%
  • Food & beverage$64552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,239 in reported general payments places this provider in the 70th percentile of 605 obstetrics & gynecology providers in Connecticut.

See all obstetrics & gynecology providers in Connecticut

Medicare billing

Part B allowed, 2024
$6,433
Medicare patients
48
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImvexxyEstradiol20$10,850
Estradiol (Twice Weekly)Estradiol32$3,608
Estradiol (Once Weekly)Estradiol19$2,302
Estradiol48$1,967
YuvafemEstradiol18$1,617
ValacyclovirValacyclovir Hcl12$964
ProgesteroneProgesterone, Micronized23$473

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Avon

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →